Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin O Leach

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Radiology|November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot StudyRaquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
The Oncologist|March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumorsChooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Maartje J Hooning, et al.
British Journal of Cancer|February 25, 2016
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisXuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studiesTimothy A Yap, David Olmos, Andre T Brunetto, et al.
Breast Cancer Research and Treatment|April 2, 2014
MRI breast screening in high-risk women: cancer detection and survival analysisD Gareth Evans, Evans D Gareth, Nisha Kesavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, et al.
Autophagy|September 14, 2019
<i>De novo</i> phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagyGabriela Andrejeva, Sharon Gowan, Gigin Lin, et al.
Magnetic Resonance Imaging|August 19, 2006
A test of performance of breast MRI interpretation in a multicentre screening studyRuth Warren, Carmel Hayes, Linda Pointon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studiesTimothy A Yap, Hendrik-Tobias Arkenau, D Ross Camidge, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Radiology|November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot StudyRaquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
The Oncologist|March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumorsChooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Maartje J Hooning, et al.
British Journal of Cancer|February 25, 2016
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisXuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studiesTimothy A Yap, David Olmos, Andre T Brunetto, et al.
Breast Cancer Research and Treatment|April 2, 2014
MRI breast screening in high-risk women: cancer detection and survival analysisD Gareth Evans, Evans D Gareth, Nisha Kesavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, et al.
Autophagy|September 14, 2019
<i>De novo</i> phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagyGabriela Andrejeva, Sharon Gowan, Gigin Lin, et al.
Magnetic Resonance Imaging|August 19, 2006
A test of performance of breast MRI interpretation in a multicentre screening studyRuth Warren, Carmel Hayes, Linda Pointon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studiesTimothy A Yap, Hendrik-Tobias Arkenau, D Ross Camidge, et al.
Pageof 19